Identifying the impact of elacestrant in clinical practice for patients with ER+/HER2- metastatic breast cancer.
Joyce O'Shaughnessy, MD
Articles by Joyce O'Shaughnessy, MD
A comprehensive review of the safety, efficacy, and subgroup analysis of the EMERALD Trial.
A discussion of the disease state, current therapies, and treatment challenges in ER+/HER2- metastatic breast cancer.
Joyce A. O'Shaughnessy, MD, discusses the phase II plasmaMATCH trial, which investigated plasma-based molecular profiling of patients with advanced breast cancer to inform therapeutic choices.